Boston Scientific Reports Second Quarter 2026 Results
Boston Scientific Corporation announced net sales of $5.442 billion for the second quarter of 2026. This represents a 7.5 percent increase on a reported basis compared to the prior year.
Marlborough, Massachusetts – Boston Scientific Corporation (NYSE: BSX) reported its financial results for the second quarter of 2026, generating net sales of $5.442 billion.
The company's net sales grew 7.5 percent on a reported basis and 7.0 percent on an operational and organic basis, when compared to the corresponding period in the previous year. This growth indicates the company's capacity to expand its sales within the medical device market.
While specific details regarding the factors contributing to this growth were not elaborated upon in the release, the figures suggest a sustained or increasing market position in a competitive healthcare sector.
Boston Scientific continues its focus on developing and marketing medical technologies across various therapeutic areas, aiming to address evolving healthcare needs worldwide.